13th Oct 2020 11:59
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 12 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,576,375 | 2.00% | 467,804 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
362,656 | 0.28% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,939,031 | 2.28% | 856,328 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 216.9000 USD |
Purchase | 1 | 217.5050 USD |
Purchase | 2 | 214.9300 USD |
Purchase | 2 | 216.7181 USD |
Purchase | 3 | 217.3200 USD |
Purchase | 6 | 216.9390 USD |
Purchase | 7 | 216.1600 USD |
Purchase | 32 | 214.4700 USD |
Purchase | 40 | 216.1680 USD |
Purchase | 63 | 216.7741 USD |
Purchase | 100 | 217.5900 USD |
Purchase | 132 | 216.2533 USD |
Purchase | 164 | 215.9912 USD |
Purchase | 200 | 216.9700 USD |
Purchase | 350 | 214.8658 USD |
Purchase | 375 | 216.5321 USD |
Purchase | 457 | 216.0115 USD |
Purchase | 1,374 | 216.1215 USD |
Purchase | 1,573 | 217.0301 USD |
Purchase | 1,850 | 216.1554 USD |
Purchase | 1,880 | 217.0304 USD |
Purchase | 1,897 | 215.7356 USD |
Purchase | 2,416 | 215.7375 USD |
Purchase | 3,058 | 217.0223 USD |
Purchase | 3,108 | 216.9647 USD |
Purchase | 3,468 | 215.7663 USD |
Purchase | 3,782 | 216.3231 USD |
Purchase | 4,000 | 215.8638 USD |
Purchase | 4,204 | 216.1086 USD |
Purchase | 12,001 | 216.7179 USD |
Purchase | 13,371 | 217.0300 USD |
Purchase | 14,640 | 216.7006 USD |
Purchase | 117,236 | 214.2956 USD |
Sale | 1 | 216.0600 USD |
Sale | 2 | 215.6550 USD |
Sale | 10 | 215.7369 USD |
Sale | 25 | 216.9500 USD |
Sale | 92 | 212.9100 USD |
Sale | 97 | 213.3900 USD |
Sale | 100 | 215.8050 USD |
Sale | 160 | 217.0050 USD |
Sale | 185 | 216.7650 USD |
Sale | 200 | 215.8350 USD |
Sale | 256 | 216.5212 USD |
Sale | 300 | 217.1754 USD |
Sale | 330 | 216.6290 USD |
Sale | 347 | 216.9480 USD |
Sale | 413 | 216.8508 USD |
Sale | 589 | 216.8633 USD |
Sale | 608 | 216.5452 USD |
Sale | 640 | 216.9180 USD |
Sale | 650 | 214.1715 USD |
Sale | 800 | 215.9580 USD |
Sale | 903 | 213.0932 USD |
Sale | 1,056 | 216.6504 USD |
Sale | 1,343 | 216.7184 USD |
Sale | 1,345 | 216.2111 USD |
Sale | 1,578 | 217.0309 USD |
Sale | 2,618 | 215.4430 USD |
Sale | 2,689 | 216.2891 USD |
Sale | 2,990 | 215.9810 USD |
Sale | 3,057 | 217.0223 USD |
Sale | 3,433 | 216.9462 USD |
Sale | 3,934 | 216.3505 USD |
Sale | 7,063 | 216.9857 USD |
Sale | 12,408 | 214.4127 USD |
Sale | 12,465 | 217.0300 USD |
Sale | 14,327 | 216.7458 USD |
Sale | 20,000 | 213.4119 USD |
Sale | 22,292 | 214.9205 USD |
Sale | 58,618 | 214.2956 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 13 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201013005594/en/
Copyright Business Wire 2020
Related Shares:
Barclays